Verastem reported $-14846000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
AstraZeneca AZN:LN -1674000000 2.8B
Curis CRIS:US $ -10.05M 0.6M
Cytokinetics CYTK:US $ -69.2M 14.4M
Epizyme EPZM:US $ -64140000 5.91M
Gilead Sciences GILD:US $ 3842M 1596M
Immunogen IMGN:US $ -34.23M 6.86M
Laboratory Of America LH:US $ 766.9M 67.8M
Novartis NOVN:VX 3.23B 246M
Pfizer PFE:US $ 7647M 1733M
Tg Therapeutics TGTX:US $ -85.13M 7.64M
Verastem VSTM:US $ -14.85M 1.1M
YTE INCY:US $ 235.41M 94.57M
Ziopharm Oncology ZIOP:US $ -22296000 343K